HC Wainwright Has Bearish Estimate for COLL Q1 Earnings
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) – Stock analysts at HC Wainwright cut their Q1 2025 EPS estimates for Collegium Pharmaceutical in a report released on Monday, March 24th. HC Wainwright analyst O. Livnat now forecasts that the specialty pharmaceutical company will post earnings per share of $1.20 for the quarter, down from their […]
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) – Stock analysts at HC Wainwright cut their Q1 2025 EPS estimates for Collegium Pharmaceutical in a report released on Monday, March 24th. HC Wainwright analyst O. Livnat now forecasts that the specialty pharmaceutical company will post earnings per share of $1.20 for the quarter, down from their […]
